Liver repopulation and carcinogenesis: Two sides of the same coin?

American Journal of Pathology

Volumn 172, Issue 4, 2008, Pages 857-864

  Marongiu, Fabio ^a   Doratiotto, Silvia ^a   Montisci, Stefania ^a   Pani, Paolo ^a   Laconi, Ezio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CONNEXIN 32; GELATINASE A; UROKINASE;

CANCER GROWTH; CANCER RISK; CELL GROWTH; CELL PROLIFERATION; DISEASE MODEL; HEPATOCYTE TRANSPLANTATION; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CELL; LIVER REGENERATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 42049093784     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070910     Document Type: Review

References (81)

1. Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, Degen JL: Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991, 66:245-256
2. Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL: Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994, 263:1149-1152
3. Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou C-N, Finegold M, Grompe M: Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tryosinaemia type I. Nat Genet 1996, 12:266-273
4. Laconi E, Sarma DSR, Pani P: Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis 1995, 16:139-142
5. Laconi E, Oren R, Mukhopadhyay DK, Hurston E, Laconi S, Pani P, Dabeva MD, Shafritz DA: Long term, near total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 1998, 158:319-329
6. Laconi S, Pillai S, Porcu PP, Shafritz DA, Pani P, Laconi E: Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol 2001, 158:771-777
7. Guha C, Sharma A, Gupta S, Alfieri A, Gorla GR, Gagandeep S, Rana S, Roy-Chowdhury N, Tanka KE, Vikram B, Roy-Chowdhury J: Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 1999, 59:5871-5874
8. Mignon A, Guidotti J-E, Mitchell C, Fabre M, Wernet A, De LaCoste A, Soubrane O, Gilgenkrantz H, Kahn A: Selective repopulation of a normal mouse liver by Fas/CD95-resistant hepatocytes. Nat Med 1998, 4:1185-1188
9. De Vree JML, Ottenhoff R, Bosma PJ, Smith AJ, Aten J, RPJ Oude-Elferink: Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 2000, 119:1720-1730
10. Kip1 enhances the transplantation efficiency of hepatocytes transferred into diseased livers. J Clin Invest 2001, 108:383-390
11. Joseph B, Kumaran V, Berishvili E, Barghava KK, Palestro CJ, Gupta S: Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning. Hepatology 2006, 44:1411-20
12. Laconi S, Laconi E: Principles of hepatocyte transplantation. Semin Cell Dev Biol 2002, 13:433-438
13. Laconi E: Differential growth: from carcinogenesis to liver repopulation. Am J Pathol 2000, 156:389-392
14. Mieles LA, Esquivel CO, Van Thiel DH, Konery B, Makowka L, Tzakis AG, Starzl TE: Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh. Dig Dis Sci 1990, 35:153-157
15. Knisely AS, Strautnieks SS, Meier Y, Stieger B, Byrne JA, Portmann BC, Bull LN, Pawlikowska L, Bilezikçi B, Ozçay F, László A, Tiszlavicz L, Moore L, Raftos J, Arnell H, Fischler B, Németh A, Papadogiannakis N, Cielecka-Kuszyk J, Jankowska I, Pawłowska J, Melín-Aldana H, Emerick KM, Whitington PF, Mieli-Vergani G, Thompson RJ: Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency Hepatology 2006, 44:478-86
16. Dandri M, Burda MR, Török E, Pollok JM, Iwanska A, Sommer G, Rogiers X, Rogler CE, Gupta S, Will H, Greten H, Petersen J: Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001, 33:981-988
17. Sandgren EP, Palmiter RD, Heckel JL, Brinster RL, Degen JL: DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice. Proc Natl Acad Sci USA 1992, 89:11523-11527
18. Petersen J, Dandri M, Gupta S, Rogler CE: Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc Natl Acad Sci USA 1999, 95:310-315
19. Demers SI, Russo P, Lettre F, Tanguay RM: Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia. Hum Pathol 2003, 34:1313-20
20. Grompe M, Lindstedt S, al-Dhalimy M, Kennaway MG, Papaconstantinou J, Torres-Ramos CA, Ou CN, Finegold M: Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat Genet 1995, 10:453-460
21. Grompe M, Overturf K, al-Dhalimy M, Finegold M: Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report. J Inherit Metab Dis 1998, 21:518-31
22. Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M, Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997, 151:1273-80
23. Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P: Self-induced correction of the genetic defect of tyrosinemia type I. J Clin Invest 1994, 94:1657-1661
24. Mauad TH, van Nieuwkerk CMJ, Dingemans KP, Smit JJM, Schinkel AH, Notenboom RGE, van den Bergh Weerman MA, Verkruisen RP, Groen AK, Oude Elferink RPJ, van der Valk MA, Borst P, Offerhaus GJA: Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 1994, 145:1237-45
25. Laconi S, Pani P, Pillai S, Pasciu D, Sarma DSR, Laconi E: A growth constrained environment drives tumor progression in vivo. Proc Natl Acad Sci USA 2001, 98:7806-7811
26. Malhi H, Gorla GR, Irani AN, Annamaneni P, Gupta S: Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation. Proc Natl Acad Sci USA 2002, 99:13114-13119
27. Geraci JP, Mariano MS: Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury. Radiat Res, 1993 136:205-213
28. Mori H, Iwata H, Morishita Y, Mori Y, Ohno T, Tanaka T, Sasaki S: Synergistic effect of radiation on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats. Jpn J Cancer Res 1990, 81:975-978
29. Kitagawa T, Nomura K, Sasaki S: Induction by X-irradiation of adenosine triphosphatase-deficient islands in the rat liver and their characterization. Cancer Res 1985, 45:6078-6082
30. Hayes MA, Robert E, Farber E: Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasiocarpine and senecionine. Cancer Res 1985, 45:3726-3734
31. Laconi E: The evolving concept of tumor microenvironments. BioEssays 2007, 29:1-7
32. Fischer AH, Young KA, DeLellis RA: Incorporating pathologists' criteria of malignancy into the evolutionary model for cancer development. J Cell Biochem 2004, 93:28-36
33. Trosko JE, Chang CC, Upham BL, Tai MH: Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication. Ann NY Acad Sci 2004, 1028:192-201
34. Steinbeck RG: Dysplasia in view of the cell cycle. Eur J Histochem 2004, 48:203-211
35. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70
36. Sakamoto H, Oyamada M, Enomoto K, Mori M: Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis in rats. Jpn J Cancer Res 1992, 83:1210-1215
37. Neveu MJ, Hully JR, Babcock KL, Hertzberg EL, Nicholson BJ, Paul DL, Pitot HC: Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver. J Cell Sci 1994, 107:83-95
38. Tsuda H, Asamoto M, Baba H, Iwahori Y, Matsumoto K, Iwase T, Nishida Y, Nagao S, Hakoi K, Yamaguchi S, Okazi K, Yamasaki H: Cell proliferation and advancement of hepatocarcinogenesis in the rat are associated with a decrease in connexin 32 expression. Carcinogenesis 1995, 16:101-105
39. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C, Yamasaki H: Altered homologous and heterologous gap junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 1994, 56:87-94
40. Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N: Expression of gap junction protein connexin 32 in chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Gastroenterol 2004, 39:763-68
41. Moennikes O, Buchmann A, Ott T, Willecke K, Schwarz M: The effect of connexin 32 null mutation on hepatocarcinogenesis in different mouse strains. Carcinogenesis 1999, 20:1379-1382
42. Zaidan-Dagli ML, Yamasaki H, Krutovskikh V, Omori Y: Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin 32 only in the liver. Carcinogenesis 2004, 25:483-492
43. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687
44. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L: EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 2002, 1:445-457
45. Plath T, Detjen K, Welzel M, von Marchall Z, Murphy D, Schirner M, Wiedenmann B, Rosewicz S: A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor. J Cell Biol 2000, 150:1467-1478
46. Yao M, Zhou XD, Zha XL, Shi DR, Fu J, He JY; Lu HF, Tang ZY: Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol 1997, 123:435-440
47. Stamatoglou SC, Manson MM, Green JA, Mayol X, Hughes RC: Distribution of fibronectin and fibronectin-binding proteins. AGp110 and integrin alpha 5 beta 1, during chemically induced hepatocarcinogenesis in adult rats J Cell Sci 1991, 100:599-604
48. Kumaran V, Joseph B, Benten D, Gupta S: Integrin and extracellular matrix interactions regulate engraftment of transplanted hepatocytes in the rat liver. Gastroenterology 2005, 129:1643-1653
49. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991, 5:2145-2151
50. Ellerbroek SM, Stack MS: Membrane associated matrix metalloproteinases in metastasis. BioEssays 1999, 21:940-949
51. Lehti K, Lohi J, Valtalen H, Keski-Oja J: Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 1998, 334:345-353
52. Bedossa P, Paradis V: Liver extracellular matrix in health and disease. J Pathol 2003, 200:504-515
53. Theret N, Musso O, L'Helgoualc'h A, Clement B: Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interaction with hepatocytes. Am J Pathol 1997, 150:51-58
54. Mazzocca A, Cappadona Sciammetta S, Carloni V, Cosmi L, Annunziato F, Harada T, Abrignani S, Pinzani M: Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase 2 in human hepatic stellate cells. J Biol Chem 2005, 280:11329-11339
55. Rudolph KL, Trautwein C, Kubicka S, Rakemann T, Bahr MJ, Sedlaczek N, Schuppan D, Manns MP: Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats. Hepatology 1999, 30:1159-1166
56. Kim T-H, Mars WM, Stolz D, Michalopoulos GK: Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology 2000, 30:75-82
57. Koenig S, Stoesser C, Krause P, Becker H, Markus PM: Liver repopulation after hepatocellular transplantation: integration and interaction of transplanted hepatocytes in the host. Cell Transplant 2005, 14:31-40
58. Ogata R, Torimura T, Kim M, Ueno T, Tateishi Y, Kuromatsu R, Shimauchi Y, Sakamoto M, Tamaki S, Sata M, Tanikawa K: Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas. Hum Pathol 1999, 30:443-450
59. Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion J-P, Boudjema K, Clement B: Increased extracellular matrixremodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 2001, 34:82-88
60. Park YN, Yang CP, Cubukcu O, Thung SN, Theise ND: Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. Liver 1997, 17:271-274
61. Rudnick DA, Perlmutter DH: Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 2005, 42:514-521
62. Perlmutter DH: Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 2006, 60:233-238
63. Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH: Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency. Hepatology 2004, 39:1048-1055
64. Hadzic N, Quaglia A, Mieli-Vergani G: Hepatocellular carcinoma in a 12-year-old child with PiZZ alpha1-antitrypsin deficiency. Hepatology 2006, 43:194
65. Wada K, Kondo F, Kondo Y: Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study. Hepatology 1988, 8:1684-1688
66. Wanless IR, International Working Party. Terminology of nodular hepatocellular lesions Hepatology 1995, 22:983-993
67. Paradis V, Laurendeau I, Vidaud M, Bedossa P: Clonal analysis of macronodules in cirrhosis. Hepatology 1998, 28:953-958
68. Park YN, Roncalli M: Large liver cell dysplasia: a controversial entity. J Hepatol 2006, 45:734-743
69. Britto Garcia S, Novelli M, Wright NA: The clonal origin and clonal evolution of epithelial tumors. Int J Exp Pathol 2000, 81:89-116
70. Libbrecht L, Desmet V, Roskams T: Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 2005, 25:16-27
71. Gaffey MJ, Iezzoni JC, Weiss LM: Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996, 148:1089-1096
72. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T: Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987, 206:30-39
73. Moser MA, Kneteman NM, Minuk GY: Research toward safer resection of the cirrhotic liver. HPB Surg 2000, 11:285-297
74. Chijiiwa K, Nakano K, Kameoka N, Nagai E, Tanaka M: Proliferating cell nuclear antigen, plasma fibronectin, and liver regeneration rate after seventy percent hepatectomy in normal and cirrhotic rats. Surgery 1994, 116:544-549
75. Kaido T, Yoshikawa A, Seto S, Yamaoka S, Sato M, Ishii T, Imamura M: Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats. Hepatology 1998, 28:756-769
76. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576
77. Michalopoulos GK: Liver regeneration. J Cell Physiol 2007, 213:286-300
78. Sigal SH, Rajvanshi P, Gorla GR, Sokhi RP, Saxena R, Gebhard DR Jr, Reid LM, Gupta S: Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J. Physiol 1999, 276:G1260-G1272
79. Pound AW, McGuire LJ: Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br J Cancer 1978, 37:585-594
80. Malhi H, Irani AN, Volemberg I, Schilsky ML, Gupta S: Early cell transplantation in LEC rat modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterology 2002, 122:438-447
81. Laconi S, Montisci S, Doratiotto S, Greco M, Pasciu D, Pillai S, Pani P, Laconi E: Liver repopulation by transplanted hepatocytes and risk of hepatocellular carcinoma. Transplantation 2006, 82:1319-1323